Orthocell’s strong sales growth Tissue regeneration technology developer Orthocell has announced sales growth across its product portfolio, with total revenue for FY24 of $6.72 million – up 30.40 percent from FY23. Record revenue of $1.84m was achieved for the June 24 Quarter, up 14.41 percent. With Striate+ currently sold in the US, Europe/UK, Australia and…
IDT Australia to raise $7 million for mRNA vaccine production Pharmaceutical manufacturer IDT Australia is to raise $7 million a fully underwritten entitlement offer of fully paid ordinary shares to eligible shareholders. The funds raised will be used to fund capital expenditure relating to current and potential future works in the mRNA therapeutics field including…
ASX-listed reproductive biotechnology company Memphasys has announced results showing “clear benefits” of its Felix technology versus two widely used technologies in a Japanese trial, with results from a larger-scale trial expected to be shared in late-2024. According to an ASX statement from the company on Monday, the Felix System (pictured) outperformed a sperm preparation method…
Envirostream to recycle LG lithium batteries Battery recycler Envirostream has signed an exclusive three year agreement with LG Energy Solutions to recycle all its recalled lithium ion batteries collected in Australia. Envirostream, a subsidiary of Lithium Australia, expects significantly increased battery collection volumes equating to 140 percent of the company’s total in FY23. LG has…
Reproductive technology company Memphasys has announced findings from a trial at a stud farm of its semen storage and transport device in November, which will lead to further work on medium and operational improvements of the AI-Port product. In an ASX statement on Thursday, the company said the trial at the Hunter region, NSW site…
NSW container scheme nears milestone The NSW Return and Earn scheme is on the verge of reaching the milestone of 10 billion recycled cans and bottles. On Friday the NSW Government encouraged households to help reach the mark in the next 24 to 48 hours, by taking their empty drink containers to one of 620…
Reproductive health technology company Memphasys has announced the first order of Felix System products placed by Vitrolife Japan, the local subsidiary of Sweden’s Vitrolife Group. Memphasys said on Monday that the order was for 150 Felix System cartridges, to be supplied to five key opinion leader (KOL) clinics in Japan. Felix is described as using…